Dr Reddys Laboratories Share Price Today - Live Blog for November 12, 2025

Dr Reddys Laboratories Ltd stock price decreased by -0.03%, with the current market value at ₹1,229.25 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% drop, and it's now trading at ₹1,229.25 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.03% in its share price, and it currently trades at ₹1,229.25 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

After a -0.04% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,230.00. The stock has a PE ratio of 17.6200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a -0.07% decrease in its share price, and it is currently trading at ₹1,229.95. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.6200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price rallied by 0.23%, reaching the current market price of ₹1,229.75. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd share price has declined by -0.11%, and it's currently trading at ₹1,226.90. The stock maintains a PE of 17.6200, while the industry PE is 33.7264, prompting discussions about its valuation.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.25% in its share price, and it currently trades at ₹1,228.20 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.27%, reaching a current market price of ₹1,231.25. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Demonstrating a commendable 0.22% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,234.30. In terms of valuation, the stock maintains a PE ratio of 17.6200, while the industry PE ratio stands at 33.7264.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.17% increase. Presently, it is actively trading at ₹1,232.10.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.07%. At this moment, it's actively trading at ₹1,230.00, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,228.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.6200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.11% upswing, and it's currently trading at ₹1,229.30 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd share price has declined by -0.02%, and it's currently trading at ₹1,229.55. The stock maintains a PE of 17.6200, while the industry PE is 33.7264, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd observed a -0.02% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,230.60. The stock has a PE ratio of 17.6200, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.03% uptick in its share price. As a result, it's now actively trading at ₹1,230.05 per share, making it an attractive option for investors.

After a notable 0.09% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,229.70. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

After a notable 0.18% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,228.65. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277%.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.07%, with its current market value per share resting at ₹1,226.50. This development highlights the stock's appeal to investors.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.04%, signalling a challenging period. Currently trading at ₹1,226.40, this stock has caught the eye of bargain hunters, who may be considering their entry points.

With a -0.08% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,226.95. The stock is currently trading at a PE of 17.6200, while the industry PE is 33.7264, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd share price has declined by -0.08%, and it's currently trading at ₹1,226.95. The stock maintains a PE of 17.6200, while the industry PE is 33.7264, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.08%, signalling a challenging period. Currently trading at ₹1,226.95, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.09%, reaching the current market price of ₹1,227.05. This development underscores the stock's growing popularity.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.48%, reaching the current market price of ₹1,225.50. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.08% drop, and it's now trading at ₹1,219.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd shares experienced a -0.09% reduction, with the current market price at ₹1,220.85. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's stock price surged by 0.33%, reaching the current market value of ₹1,222.00 per share. This surge is a testament to the stock's recent performance.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.41%, signalling a challenging period. Currently trading at ₹1,217.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.